Johnson & Johnson looks to settle morcellator lawsuits
Johnson & Johnson(NYSE:JNJ) is reportedly looking to settle 100s of product liability and wrongful death lawsuits brought over its now-recalled laparoscopic power morcellators used during surgeries to remove ostensibly benign uterine tumors. The morcellators, which use a cutting tip to shred and remove uterine tissue, have been implicated in the spread of a lethal cancer that can masquerade undetected as benign fibroids. The FDA in April 2014 issued a warning about the devices, later convening a special advisory panel to evaluate their continued use in the surgical suite. The watchdog agency estimates that about 0....
Source: Mass Device - March 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Product Liability Surgical Ethicon Inc. Johnson & Johnson Source Type: news

Learn About Each Type of Colon Cancer
Adenocarcinoma is the most common type of colon cancer but there are many other forms as well. Examples include leiomyosarcoma, lymphoma, melanoma, and neuroendocrine tumors. Here, you can learn more about each type of colon cancer. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - March 1, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news

Just what is Leiomyosarcoma?
Leiomyosarcomas account for less than two percent of colorectal cancers and have a fairly high chance of spreading. Learn more about leiomyosarcomas. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 26, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news

Primary Leiomyosarcoma of the Submandibular GlandPrimary Leiomyosarcoma of the Submandibular Gland
Leiomyosarcoma is a rare malignant mesenchymal tumor; and even rarer in the salivary gland. How was diagnosis ascertained in this case? BMC Clinical Pathology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 29, 2016 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Janssen's Yondelis gets FDA approval to treat unresectable or metastatic LPS or LMS
Janssen Biotech has received approval from the US Food and Drug Administration (FDA) for Yondelis (trabectedin) to treat patients with unresectable or metastatic liposarcoma (LPS) or leiomyosarcoma (LMS) who received a prior anthracycline-containing … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 26, 2015 Category: Pharmaceuticals Source Type: news

FDA approves new therapy for certain types of advanced soft tissue sarcoma
The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who previously received chemotherapy that contained anthracycline. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 23, 2015 Category: American Health Source Type: news

World's First Partial Skull And Scalp Transplant A Success In Texas
Opening a new frontier in transplant surgery, Texas doctors have done the world's first partial skull and scalp transplant to help a man who suffered a large head wound from cancer treatment. Doctors from Houston Methodist Hospital and MD Anderson Cancer Center did the operation two weeks ago. The recipient — Jim Boysen, a 55-year-old software developer from Austin, Texas — expects to leave the hospital Thursday with a new kidney and pancreas along with the scalp and skull grafts. He said he was stunned at how well doctors matched him to a donor with similar skin and hair coloring. "It's kind of shocking, really, ho...
Source: Science - The Huffington Post - June 5, 2015 Category: Science Source Type: news

World's First Skull-Cap Transplant Helps Jim Boysen Fight Cancer
Opening a new frontier in transplant surgery, Texas doctors have done the world's first partial skull and scalp transplant to help a man who suffered a large head wound from cancer treatment. Doctors from Houston Methodist Hospital and MD Anderson Cancer Center did the operation two weeks ago. The recipient - Jim Boysen, a 55-year-old software developer from Austin, Texas - expects to leave the hospital Thursday with a new kidney and pancreas along with the scalp and skull grafts. He said he was stunned at how well doctors matched him to a donor with similar skin and hair coloring. "It's kind of shocking, really, how go...
Source: Science - The Huffington Post - June 5, 2015 Category: Science Source Type: news

Fibroid Morcellation Gets Boost From New Study (CME/CE)
(MedPage Today) -- But procedure was linked to more leiomyosarcoma deaths. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 25, 2015 Category: Primary Care Source Type: news

Leiomyosarcoma of the Colon and Rectum
Colorectal sarcomas occur in the smooth muscle of the colon and are called leiomyosarcomas. Leiomyosarcomas account for less than two percent of colorectal cancers and have a fairly high chance of spreading. (Source: About.com Colon Cancer)
Source: About.com Colon Cancer - February 22, 2015 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news

Power Morcellator Cancer Risk Confirmed by FDA, As Bernstein Liebhard...
The FDA's new morcelltor cancer warning comes amid growing concerns that uterine morcellation may have caused numerous women to experience the spread of uterine sarcoma, leiomyosarcoma and other...(PRWeb November 25, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12355345.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 26, 2014 Category: Pharmaceuticals Source Type: news

PharmaMar announces US partner Janssen files NDA for YONDELIS for soft-tissue sarcoma
(Pharmamar) Based on a phase 3 trial in which dacarbazine was used in the comparator arm, Janssen has submitted a NDA for YONDELIS (trabectedin) to the FDA for the treatment of patients with advanced soft tissue sarcoma, including liposarcoma and leiomyosarcoma, who have received prior chemotherapy including an anthracycline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2014 Category: Cancer & Oncology Source Type: news

Uterine Leiomyosarcoma: Rare Tumor in Clinical TrialsUterine Leiomyosarcoma: Rare Tumor in Clinical Trials
Dr Martee Hensley discusses the difficulty in differentiating benign uterine fibroids from malignancy, the controversy over morcellation, and initiatives undertaken to manage uterine leiomyosarcoma. Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 19, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology Expert Interview Source Type: news

Power Morcellator News: Bernstein Liebhard LLP Notes Uncle’s Plea to...
The Firm is evaluating potential morcellator lawsuits on behalf of woman who allegedly experienced the spread of gynecological cancers, including uterine sarcoma and leiomyosarcoma, following uterine...(PRWeb November 17, 2014)Read the full story at http://www.prweb.com/releases/morcellator-lawsuit/morcellator-cancer/prweb12332279.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 18, 2014 Category: Pharmaceuticals Source Type: news

Mycosis Fungoides and Leiomyosarcoma – Cancer Therapeutic Drugs and...
RnRMarketResearch.com adds “Mycosis Fungoides and Leiomyosarcoma – Pipeline Review, H2 2014” to its store. The report provides an overview of the Mycosis Fungoides and Leiomyosarcoma therapeutic...(PRWeb October 31, 2014)Read the full story at http://www.prweb.com/releases/2014-h2-retinoblastoma/leiomyosarcoma-pipeline/prweb12293087.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 1, 2014 Category: Pharmaceuticals Source Type: news